P
Pascale Beyne
Researcher at Beaujon Hospital
Publications - 8
Citations - 959
Pascale Beyne is an academic researcher from Beaujon Hospital. The author has contributed to research in topics: Heart failure & Brain natriuretic peptide. The author has an hindex of 5, co-authored 8 publications receiving 916 citations.
Papers
More filters
Journal ArticleDOI
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
Damien Logeart,Gabriel Thabut,Patrick Jourdain,Christophe Chavelas,Pascale Beyne,Florence Beauvais,Erik Bouvier,Alain Cohen Solal +7 more
TL;DR: High predischarge BNP assay is a strong, independent marker of death or re-admission after decompensated CHF, more relevant than common clinical or echocardiographic parameters and morerelevant than changes in BNP levels during acute cares.
Journal ArticleDOI
Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea
Damien Logeart,Carole Saudubray,Pascale Beyne,Gabriel Thabut,Pierre-Vladimir Ennezat,Christophe Chavelas,Caroline Zanker,Erik Bouvier,Alain Cohen Solal +8 more
TL;DR: Bedside BNP measurement and Doppler echocardiography are both useful for establishing the cause of acute dyspnea, but doppler analysis of the mitral inflow pattern was more accurate, particularly in patients with intermediate BNP levels or "flash" pulmonary edema.
Journal ArticleDOI
Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain.
Damien Logeart,Pascale Beyne,Christine Cusson,Maria Tokmakova,Monique Leban,Chabnam Guiti,Pierre Bourgoin,Alain Cohen Solal +7 more
TL;DR: In this paper, the authors used the cardiac troponin I (cTnI) assay to assess the role of myocyte death in heart failure irrespective of the presence of coronary artery disease.
Journal ArticleDOI
Comparison of single and repeat centrifugation of blood specimens collected in BD evacuated blood collection tubes containing a clot activator for cardiac troponin I assay on the ACCESS analyzer.
TL;DR: Cardiac troponin I has become a major marker in the diagnosis and monitoring of myocardial damage and residual fibrin and microparticles have been reported to interfere with one or more cTnI assays.
Journal ArticleDOI
Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.
TL;DR: It was concluded that the recommended cefazolin-dosing schedule was suitable in all tested populations, including obese patients, although prolongation of the interval between injections appeared advisable for renal insufficiency patients.